nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—HTR7—coronary artery disease	0.155	0.665	CbGaD
Ziprasidone—HTR2A—coronary artery disease	0.0778	0.335	CbGaD
Ziprasidone—HTR1B—Penbutolol—coronary artery disease	0.0437	0.117	CbGbCtD
Ziprasidone—HTR1A—Penbutolol—coronary artery disease	0.0274	0.073	CbGbCtD
Ziprasidone—CYP3A7—Eplerenone—coronary artery disease	0.0176	0.047	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0176	0.047	CbGbCtD
Ziprasidone—CYP3A5—Clopidogrel—coronary artery disease	0.0142	0.0379	CbGbCtD
Ziprasidone—CYP3A5—Eplerenone—coronary artery disease	0.0132	0.0352	CbGbCtD
Ziprasidone—CYP1A2—Gemfibrozil—coronary artery disease	0.0122	0.0325	CbGbCtD
Ziprasidone—CYP3A7—Simvastatin—coronary artery disease	0.0113	0.0303	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.0113	0.0303	CbGbCtD
Ziprasidone—CYP3A7—Lovastatin—coronary artery disease	0.0111	0.0296	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.0111	0.0296	CbGbCtD
Ziprasidone—CYP1A2—Clopidogrel—coronary artery disease	0.0106	0.0282	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.0101	0.027	CbGbCtD
Ziprasidone—CYP3A7—Atorvastatin—coronary artery disease	0.0101	0.027	CbGbCtD
Ziprasidone—CYP3A5—Rosuvastatin—coronary artery disease	0.00916	0.0244	CbGbCtD
Ziprasidone—KCNH2—purkinje fiber—coronary artery disease	0.00905	0.181	CbGeAlD
Ziprasidone—CYP3A4—Ticagrelor—coronary artery disease	0.00897	0.0239	CbGbCtD
Ziprasidone—CYP3A5—Simvastatin—coronary artery disease	0.00851	0.0227	CbGbCtD
Ziprasidone—CYP3A5—Lovastatin—coronary artery disease	0.00833	0.0222	CbGbCtD
Ziprasidone—CYP3A5—Pravastatin—coronary artery disease	0.00833	0.0222	CbGbCtD
Ziprasidone—CYP3A4—Fenofibrate—coronary artery disease	0.00799	0.0213	CbGbCtD
Ziprasidone—CYP3A5—Atorvastatin—coronary artery disease	0.00759	0.0202	CbGbCtD
Ziprasidone—CYP3A5—Losartan—coronary artery disease	0.00694	0.0185	CbGbCtD
Ziprasidone—CYP2D6—Niacin—coronary artery disease	0.0066	0.0176	CbGbCtD
Ziprasidone—CYP3A4—Gemfibrozil—coronary artery disease	0.00639	0.017	CbGbCtD
Ziprasidone—CYP2D6—Timolol—coronary artery disease	0.00614	0.0164	CbGbCtD
Ziprasidone—CYP3A4—Clopidogrel—coronary artery disease	0.00554	0.0148	CbGbCtD
Ziprasidone—CYP2D6—Captopril—coronary artery disease	0.0054	0.0144	CbGbCtD
Ziprasidone—CYP2D6—Simvastatin—coronary artery disease	0.00522	0.0139	CbGbCtD
Ziprasidone—CYP1A2—Losartan—coronary artery disease	0.00516	0.0138	CbGbCtD
Ziprasidone—CYP3A4—Eplerenone—coronary artery disease	0.00515	0.0137	CbGbCtD
Ziprasidone—CYP2D6—Pravastatin—coronary artery disease	0.00511	0.0136	CbGbCtD
Ziprasidone—CYP2D6—Lovastatin—coronary artery disease	0.00511	0.0136	CbGbCtD
Ziprasidone—KCNH2—endocardium—coronary artery disease	0.00466	0.0935	CbGeAlD
Ziprasidone—CYP2D6—Atorvastatin—coronary artery disease	0.00465	0.0124	CbGbCtD
Ziprasidone—CYP3A4—Enalapril—coronary artery disease	0.00459	0.0122	CbGbCtD
Ziprasidone—CYP3A4—Ezetimibe—coronary artery disease	0.00357	0.00952	CbGbCtD
Ziprasidone—CYP3A4—Rosuvastatin—coronary artery disease	0.00357	0.00952	CbGbCtD
Ziprasidone—CYP3A4—Simvastatin—coronary artery disease	0.00332	0.00885	CbGbCtD
Ziprasidone—CYP3A4—Lovastatin—coronary artery disease	0.00325	0.00866	CbGbCtD
Ziprasidone—CYP3A4—Pravastatin—coronary artery disease	0.00325	0.00866	CbGbCtD
Ziprasidone—CYP3A4—Atorvastatin—coronary artery disease	0.00296	0.00789	CbGbCtD
Ziprasidone—HTR3A—vagus nerve—coronary artery disease	0.00295	0.0591	CbGeAlD
Ziprasidone—CYP3A4—Losartan—coronary artery disease	0.00271	0.00722	CbGbCtD
Ziprasidone—HTR7—pulmonary artery—coronary artery disease	0.00203	0.0406	CbGeAlD
Ziprasidone—HTR7—sympathetic nervous system—coronary artery disease	0.00197	0.0395	CbGeAlD
Ziprasidone—HTR2A—arteriole—coronary artery disease	0.00193	0.0387	CbGeAlD
Ziprasidone—HTR7—vagus nerve—coronary artery disease	0.00191	0.0383	CbGeAlD
Ziprasidone—HTR7—vein—coronary artery disease	0.00184	0.037	CbGeAlD
Ziprasidone—HTR7—autonomic nervous system—coronary artery disease	0.00132	0.0266	CbGeAlD
Ziprasidone—HTR2A—pulmonary artery—coronary artery disease	0.00126	0.0253	CbGeAlD
Ziprasidone—HTR2A—sympathetic nervous system—coronary artery disease	0.00123	0.0246	CbGeAlD
Ziprasidone—HTR2A—vagus nerve—coronary artery disease	0.00119	0.0239	CbGeAlD
Ziprasidone—Lurasidone—HTR7—coronary artery disease	0.00116	0.407	CrCbGaD
Ziprasidone—HTR2A—vein—coronary artery disease	0.00115	0.023	CbGeAlD
Ziprasidone—HTR1B—artery—coronary artery disease	0.000973	0.0195	CbGeAlD
Ziprasidone—HTR1D—artery—coronary artery disease	0.000942	0.0189	CbGeAlD
Ziprasidone—DRD4—heart—coronary artery disease	0.000879	0.0176	CbGeAlD
Ziprasidone—HTR2A—autonomic nervous system—coronary artery disease	0.000826	0.0166	CbGeAlD
Ziprasidone—HTR7—artery—coronary artery disease	0.000751	0.0151	CbGeAlD
Ziprasidone—H1F0—cardiac ventricle—coronary artery disease	0.000682	0.0137	CbGeAlD
Ziprasidone—H1F0—myocardium—coronary artery disease	0.000642	0.0129	CbGeAlD
Ziprasidone—HTR7—endothelium—coronary artery disease	0.000634	0.0127	CbGeAlD
Ziprasidone—Lurasidone—HTR2A—coronary artery disease	0.000584	0.205	CrCbGaD
Ziprasidone—HTR2A—artery—coronary artery disease	0.000468	0.00939	CbGeAlD
Ziprasidone—H1F0—heart—coronary artery disease	0.000448	0.00899	CbGeAlD
Ziprasidone—H1F0—cardiovascular system—coronary artery disease	0.000423	0.00848	CbGeAlD
Ziprasidone—HTR2A—endothelium—coronary artery disease	0.000395	0.00793	CbGeAlD
Ziprasidone—KCNH2—cardiac ventricle—coronary artery disease	0.000392	0.00787	CbGeAlD
Ziprasidone—ADRA2C—cardiac ventricle—coronary artery disease	0.000387	0.00776	CbGeAlD
Ziprasidone—H1F0—cardiac atrium—coronary artery disease	0.000383	0.00768	CbGeAlD
Ziprasidone—KCNH2—myocardium—coronary artery disease	0.000369	0.0074	CbGeAlD
Ziprasidone—ADRA2C—myocardium—coronary artery disease	0.000364	0.0073	CbGeAlD
Ziprasidone—CHRM2—heart—coronary artery disease	0.000357	0.00715	CbGeAlD
Ziprasidone—HTR1B—cardiovascular system—coronary artery disease	0.000338	0.00678	CbGeAlD
Ziprasidone—CHRM2—cardiovascular system—coronary artery disease	0.000336	0.00675	CbGeAlD
Ziprasidone—H1F0—blood—coronary artery disease	0.000334	0.00671	CbGeAlD
Ziprasidone—HTR1D—cardiovascular system—coronary artery disease	0.000328	0.00657	CbGeAlD
Ziprasidone—HTR3A—blood—coronary artery disease	0.000319	0.00639	CbGeAlD
Ziprasidone—CHRM1—cardiovascular system—coronary artery disease	0.000306	0.00614	CbGeAlD
Ziprasidone—Aripiprazole—HTR7—coronary artery disease	0.000277	0.0971	CrCbGaD
Ziprasidone—HTR7—heart—coronary artery disease	0.000276	0.00554	CbGeAlD
Ziprasidone—HTR1A—cardiovascular system—coronary artery disease	0.000273	0.00547	CbGeAlD
Ziprasidone—ADRA1A—heart—coronary artery disease	0.000267	0.00535	CbGeAlD
Ziprasidone—HTR7—cardiovascular system—coronary artery disease	0.000261	0.00523	CbGeAlD
Ziprasidone—KCNH2—heart—coronary artery disease	0.000258	0.00517	CbGeAlD
Ziprasidone—ADRA2C—heart—coronary artery disease	0.000254	0.0051	CbGeAlD
Ziprasidone—ADRA1A—cardiovascular system—coronary artery disease	0.000252	0.00505	CbGeAlD
Ziprasidone—SLC6A4—blood—coronary artery disease	0.000243	0.00488	CbGeAlD
Ziprasidone—KCNH2—cardiovascular system—coronary artery disease	0.000243	0.00487	CbGeAlD
Ziprasidone—Aripiprazole—ADRB1—coronary artery disease	0.000237	0.0831	CrCbGaD
Ziprasidone—KCNH2—cardiac atrium—coronary artery disease	0.00022	0.00442	CbGeAlD
Ziprasidone—ADRA2C—cardiac atrium—coronary artery disease	0.000217	0.00436	CbGeAlD
Ziprasidone—HTR7—blood—coronary artery disease	0.000206	0.00414	CbGeAlD
Ziprasidone—ADRA2A—heart—coronary artery disease	0.000203	0.00407	CbGeAlD
Ziprasidone—ADRA1A—blood—coronary artery disease	0.000199	0.00399	CbGeAlD
Ziprasidone—KCNH2—blood—coronary artery disease	0.000192	0.00385	CbGeAlD
Ziprasidone—ADRA2C—blood—coronary artery disease	0.00019	0.0038	CbGeAlD
Ziprasidone—ADRA2A—cardiac atrium—coronary artery disease	0.000173	0.00348	CbGeAlD
Ziprasidone—HTR2A—heart—coronary artery disease	0.000172	0.00346	CbGeAlD
Ziprasidone—CYP1A2—blood—coronary artery disease	0.000165	0.0033	CbGeAlD
Ziprasidone—HTR2A—cardiovascular system—coronary artery disease	0.000163	0.00326	CbGeAlD
Ziprasidone—CYP3A5—blood—coronary artery disease	0.000159	0.00318	CbGeAlD
Ziprasidone—ADRA2A—blood—coronary artery disease	0.000151	0.00303	CbGeAlD
Ziprasidone—Clozapine—HTR7—coronary artery disease	0.000149	0.0522	CrCbGaD
Ziprasidone—Aripiprazole—HTR2A—coronary artery disease	0.000139	0.0488	CrCbGaD
Ziprasidone—Trazodone—HTR2A—coronary artery disease	0.000139	0.0486	CrCbGaD
Ziprasidone—HTR2A—blood—coronary artery disease	0.000129	0.00258	CbGeAlD
Ziprasidone—CYP3A4—blood—coronary artery disease	0.000119	0.00239	CbGeAlD
Ziprasidone—CYP2D6—blood—coronary artery disease	0.000117	0.00235	CbGeAlD
Ziprasidone—Clozapine—CYP2C19—coronary artery disease	9.24e-05	0.0324	CrCbGaD
Ziprasidone—Clozapine—HTR2A—coronary artery disease	7.49e-05	0.0262	CrCbGaD
Ziprasidone—Dyspepsia—Losartan—coronary artery disease	3.39e-05	0.000167	CcSEcCtD
Ziprasidone—Feeling abnormal—Perindopril—coronary artery disease	3.38e-05	0.000167	CcSEcCtD
Ziprasidone—Headache—Lovastatin—coronary artery disease	3.37e-05	0.000166	CcSEcCtD
Ziprasidone—Dry mouth—Ramipril—coronary artery disease	3.37e-05	0.000166	CcSEcCtD
Ziprasidone—Arthralgia—Timolol—coronary artery disease	3.36e-05	0.000166	CcSEcCtD
Ziprasidone—Chest pain—Timolol—coronary artery disease	3.36e-05	0.000166	CcSEcCtD
Ziprasidone—Myalgia—Timolol—coronary artery disease	3.36e-05	0.000166	CcSEcCtD
Ziprasidone—Vomiting—Ezetimibe—coronary artery disease	3.36e-05	0.000166	CcSEcCtD
Ziprasidone—Hypersensitivity—Pravastatin—coronary artery disease	3.35e-05	0.000165	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Perindopril—coronary artery disease	3.35e-05	0.000165	CcSEcCtD
Ziprasidone—Anxiety—Timolol—coronary artery disease	3.35e-05	0.000165	CcSEcCtD
Ziprasidone—Angioedema—Lisinopril—coronary artery disease	3.35e-05	0.000165	CcSEcCtD
Ziprasidone—Decreased appetite—Losartan—coronary artery disease	3.34e-05	0.000165	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	3.34e-05	0.000165	CcSEcCtD
Ziprasidone—Abdominal pain—Captopril—coronary artery disease	3.34e-05	0.000165	CcSEcCtD
Ziprasidone—Body temperature increased—Captopril—coronary artery disease	3.34e-05	0.000165	CcSEcCtD
Ziprasidone—Dizziness—Simvastatin—coronary artery disease	3.33e-05	0.000164	CcSEcCtD
Ziprasidone—Rash—Ezetimibe—coronary artery disease	3.33e-05	0.000164	CcSEcCtD
Ziprasidone—Dermatitis—Ezetimibe—coronary artery disease	3.33e-05	0.000164	CcSEcCtD
Ziprasidone—Confusional state—Ramipril—coronary artery disease	3.33e-05	0.000164	CcSEcCtD
Ziprasidone—Asthenia—Niacin—coronary artery disease	3.32e-05	0.000164	CcSEcCtD
Ziprasidone—Fatigue—Losartan—coronary artery disease	3.32e-05	0.000164	CcSEcCtD
Ziprasidone—Headache—Ezetimibe—coronary artery disease	3.31e-05	0.000163	CcSEcCtD
Ziprasidone—Vertigo—Lisinopril—coronary artery disease	3.29e-05	0.000162	CcSEcCtD
Ziprasidone—Dry mouth—Timolol—coronary artery disease	3.29e-05	0.000162	CcSEcCtD
Ziprasidone—Constipation—Losartan—coronary artery disease	3.29e-05	0.000162	CcSEcCtD
Ziprasidone—Syncope—Lisinopril—coronary artery disease	3.29e-05	0.000162	CcSEcCtD
Ziprasidone—Vomiting—Eplerenone—coronary artery disease	3.29e-05	0.000162	CcSEcCtD
Ziprasidone—Feeling abnormal—Furosemide—coronary artery disease	3.29e-05	0.000162	CcSEcCtD
Ziprasidone—Leukopenia—Lisinopril—coronary artery disease	3.28e-05	0.000162	CcSEcCtD
Ziprasidone—Nausea—Fenofibrate—coronary artery disease	3.28e-05	0.000162	CcSEcCtD
Ziprasidone—Asthenia—Pravastatin—coronary artery disease	3.27e-05	0.000161	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Furosemide—coronary artery disease	3.26e-05	0.000161	CcSEcCtD
Ziprasidone—Rash—Eplerenone—coronary artery disease	3.26e-05	0.000161	CcSEcCtD
Ziprasidone—Urticaria—Perindopril—coronary artery disease	3.26e-05	0.000161	CcSEcCtD
Ziprasidone—Hypersensitivity—Trandolapril—coronary artery disease	3.26e-05	0.000161	CcSEcCtD
Ziprasidone—Dermatitis—Eplerenone—coronary artery disease	3.26e-05	0.000161	CcSEcCtD
Ziprasidone—Diarrhoea—Valsartan—coronary artery disease	3.25e-05	0.00016	CcSEcCtD
Ziprasidone—Confusional state—Timolol—coronary artery disease	3.25e-05	0.00016	CcSEcCtD
Ziprasidone—Shock—Ramipril—coronary artery disease	3.25e-05	0.00016	CcSEcCtD
Ziprasidone—Hypersensitivity—Enalapril—coronary artery disease	3.24e-05	0.00016	CcSEcCtD
Ziprasidone—Abdominal pain—Perindopril—coronary artery disease	3.24e-05	0.00016	CcSEcCtD
Ziprasidone—Body temperature increased—Perindopril—coronary artery disease	3.24e-05	0.00016	CcSEcCtD
Ziprasidone—Palpitations—Lisinopril—coronary artery disease	3.24e-05	0.00016	CcSEcCtD
Ziprasidone—Diarrhoea—Olmesartan—coronary artery disease	3.24e-05	0.00016	CcSEcCtD
Ziprasidone—Headache—Eplerenone—coronary artery disease	3.24e-05	0.00016	CcSEcCtD
Ziprasidone—Nervous system disorder—Ramipril—coronary artery disease	3.23e-05	0.000159	CcSEcCtD
Ziprasidone—Thrombocytopenia—Ramipril—coronary artery disease	3.23e-05	0.000159	CcSEcCtD
Ziprasidone—Loss of consciousness—Lisinopril—coronary artery disease	3.22e-05	0.000159	CcSEcCtD
Ziprasidone—Nausea—Clopidogrel—coronary artery disease	3.22e-05	0.000159	CcSEcCtD
Ziprasidone—Tachycardia—Ramipril—coronary artery disease	3.22e-05	0.000159	CcSEcCtD
Ziprasidone—Skin disorder—Ramipril—coronary artery disease	3.2e-05	0.000158	CcSEcCtD
Ziprasidone—Infection—Timolol—coronary artery disease	3.2e-05	0.000158	CcSEcCtD
Ziprasidone—Vomiting—Simvastatin—coronary artery disease	3.2e-05	0.000158	CcSEcCtD
Ziprasidone—Hypersensitivity—Telmisartan—coronary artery disease	3.2e-05	0.000158	CcSEcCtD
Ziprasidone—Cough—Lisinopril—coronary artery disease	3.2e-05	0.000158	CcSEcCtD
Ziprasidone—Nausea—Lovastatin—coronary artery disease	3.2e-05	0.000158	CcSEcCtD
Ziprasidone—Hyperhidrosis—Ramipril—coronary artery disease	3.19e-05	0.000157	CcSEcCtD
Ziprasidone—Rash—Simvastatin—coronary artery disease	3.18e-05	0.000157	CcSEcCtD
Ziprasidone—Dermatitis—Simvastatin—coronary artery disease	3.17e-05	0.000156	CcSEcCtD
Ziprasidone—Asthenia—Trandolapril—coronary artery disease	3.17e-05	0.000156	CcSEcCtD
Ziprasidone—Shock—Timolol—coronary artery disease	3.17e-05	0.000156	CcSEcCtD
Ziprasidone—Feeling abnormal—Losartan—coronary artery disease	3.17e-05	0.000156	CcSEcCtD
Ziprasidone—Urticaria—Furosemide—coronary artery disease	3.17e-05	0.000156	CcSEcCtD
Ziprasidone—Diarrhoea—Niacin—coronary artery disease	3.16e-05	0.000156	CcSEcCtD
Ziprasidone—Nervous system disorder—Timolol—coronary artery disease	3.16e-05	0.000156	CcSEcCtD
Ziprasidone—Asthenia—Enalapril—coronary artery disease	3.16e-05	0.000156	CcSEcCtD
Ziprasidone—Headache—Simvastatin—coronary artery disease	3.16e-05	0.000156	CcSEcCtD
Ziprasidone—Body temperature increased—Furosemide—coronary artery disease	3.15e-05	0.000155	CcSEcCtD
Ziprasidone—Abdominal pain—Furosemide—coronary artery disease	3.15e-05	0.000155	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Losartan—coronary artery disease	3.15e-05	0.000155	CcSEcCtD
Ziprasidone—Dizziness—Valsartan—coronary artery disease	3.15e-05	0.000155	CcSEcCtD
Ziprasidone—Anorexia—Ramipril—coronary artery disease	3.14e-05	0.000155	CcSEcCtD
Ziprasidone—Nausea—Ezetimibe—coronary artery disease	3.14e-05	0.000155	CcSEcCtD
Ziprasidone—Skin disorder—Timolol—coronary artery disease	3.13e-05	0.000154	CcSEcCtD
Ziprasidone—Dizziness—Olmesartan—coronary artery disease	3.13e-05	0.000154	CcSEcCtD
Ziprasidone—Arthralgia—Lisinopril—coronary artery disease	3.12e-05	0.000154	CcSEcCtD
Ziprasidone—Myalgia—Lisinopril—coronary artery disease	3.12e-05	0.000154	CcSEcCtD
Ziprasidone—Chest pain—Lisinopril—coronary artery disease	3.12e-05	0.000154	CcSEcCtD
Ziprasidone—Hyperhidrosis—Timolol—coronary artery disease	3.12e-05	0.000154	CcSEcCtD
Ziprasidone—Asthenia—Telmisartan—coronary artery disease	3.12e-05	0.000154	CcSEcCtD
Ziprasidone—Diarrhoea—Pravastatin—coronary artery disease	3.12e-05	0.000154	CcSEcCtD
Ziprasidone—Anxiety—Lisinopril—coronary artery disease	3.11e-05	0.000153	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	3.1e-05	0.000153	CcSEcCtD
Ziprasidone—Hypotension—Ramipril—coronary artery disease	3.08e-05	0.000152	CcSEcCtD
Ziprasidone—Anorexia—Timolol—coronary artery disease	3.07e-05	0.000152	CcSEcCtD
Ziprasidone—Nausea—Eplerenone—coronary artery disease	3.07e-05	0.000151	CcSEcCtD
Ziprasidone—Dizziness—Niacin—coronary artery disease	3.06e-05	0.000151	CcSEcCtD
Ziprasidone—Urticaria—Losartan—coronary artery disease	3.06e-05	0.000151	CcSEcCtD
Ziprasidone—Dry mouth—Lisinopril—coronary artery disease	3.05e-05	0.00015	CcSEcCtD
Ziprasidone—Body temperature increased—Losartan—coronary artery disease	3.04e-05	0.00015	CcSEcCtD
Ziprasidone—Abdominal pain—Losartan—coronary artery disease	3.04e-05	0.00015	CcSEcCtD
Ziprasidone—Asthenia—Captopril—coronary artery disease	3.03e-05	0.000149	CcSEcCtD
Ziprasidone—Diarrhoea—Trandolapril—coronary artery disease	3.03e-05	0.000149	CcSEcCtD
Ziprasidone—Vomiting—Valsartan—coronary artery disease	3.02e-05	0.000149	CcSEcCtD
Ziprasidone—Confusional state—Lisinopril—coronary artery disease	3.02e-05	0.000149	CcSEcCtD
Ziprasidone—Diarrhoea—Enalapril—coronary artery disease	3.01e-05	0.000149	CcSEcCtD
Ziprasidone—Hypotension—Timolol—coronary artery disease	3.01e-05	0.000149	CcSEcCtD
Ziprasidone—Dizziness—Pravastatin—coronary artery disease	3.01e-05	0.000148	CcSEcCtD
Ziprasidone—Vomiting—Olmesartan—coronary artery disease	3.01e-05	0.000148	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Ramipril—coronary artery disease	3.01e-05	0.000148	CcSEcCtD
Ziprasidone—Rash—Valsartan—coronary artery disease	3e-05	0.000148	CcSEcCtD
Ziprasidone—Dermatitis—Valsartan—coronary artery disease	3e-05	0.000148	CcSEcCtD
Ziprasidone—Nausea—Simvastatin—coronary artery disease	2.99e-05	0.000148	CcSEcCtD
Ziprasidone—Rash—Olmesartan—coronary artery disease	2.98e-05	0.000147	CcSEcCtD
Ziprasidone—Insomnia—Ramipril—coronary artery disease	2.98e-05	0.000147	CcSEcCtD
Ziprasidone—Dermatitis—Olmesartan—coronary artery disease	2.98e-05	0.000147	CcSEcCtD
Ziprasidone—Headache—Valsartan—coronary artery disease	2.98e-05	0.000147	CcSEcCtD
Ziprasidone—Diarrhoea—Telmisartan—coronary artery disease	2.97e-05	0.000147	CcSEcCtD
Ziprasidone—Infection—Lisinopril—coronary artery disease	2.97e-05	0.000147	CcSEcCtD
Ziprasidone—Headache—Olmesartan—coronary artery disease	2.97e-05	0.000146	CcSEcCtD
Ziprasidone—Paraesthesia—Ramipril—coronary artery disease	2.96e-05	0.000146	CcSEcCtD
Ziprasidone—Shock—Lisinopril—coronary artery disease	2.94e-05	0.000145	CcSEcCtD
Ziprasidone—Asthenia—Perindopril—coronary artery disease	2.94e-05	0.000145	CcSEcCtD
Ziprasidone—Dyspnoea—Ramipril—coronary artery disease	2.94e-05	0.000145	CcSEcCtD
Ziprasidone—Vomiting—Niacin—coronary artery disease	2.94e-05	0.000145	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Timolol—coronary artery disease	2.94e-05	0.000145	CcSEcCtD
Ziprasidone—Hypersensitivity—Furosemide—coronary artery disease	2.94e-05	0.000145	CcSEcCtD
Ziprasidone—Somnolence—Ramipril—coronary artery disease	2.93e-05	0.000145	CcSEcCtD
Ziprasidone—Thrombocytopenia—Lisinopril—coronary artery disease	2.93e-05	0.000144	CcSEcCtD
Ziprasidone—Dizziness—Trandolapril—coronary artery disease	2.92e-05	0.000144	CcSEcCtD
Ziprasidone—Tachycardia—Lisinopril—coronary artery disease	2.92e-05	0.000144	CcSEcCtD
Ziprasidone—Insomnia—Timolol—coronary artery disease	2.92e-05	0.000144	CcSEcCtD
Ziprasidone—Rash—Niacin—coronary artery disease	2.92e-05	0.000144	CcSEcCtD
Ziprasidone—Dermatitis—Niacin—coronary artery disease	2.91e-05	0.000144	CcSEcCtD
Ziprasidone—Dizziness—Enalapril—coronary artery disease	2.91e-05	0.000144	CcSEcCtD
Ziprasidone—Skin disorder—Lisinopril—coronary artery disease	2.91e-05	0.000143	CcSEcCtD
Ziprasidone—Dyspepsia—Ramipril—coronary artery disease	2.9e-05	0.000143	CcSEcCtD
Ziprasidone—Headache—Niacin—coronary artery disease	2.9e-05	0.000143	CcSEcCtD
Ziprasidone—Paraesthesia—Timolol—coronary artery disease	2.9e-05	0.000143	CcSEcCtD
Ziprasidone—Vomiting—Pravastatin—coronary artery disease	2.9e-05	0.000143	CcSEcCtD
Ziprasidone—Hyperhidrosis—Lisinopril—coronary artery disease	2.89e-05	0.000143	CcSEcCtD
Ziprasidone—Diarrhoea—Captopril—coronary artery disease	2.89e-05	0.000143	CcSEcCtD
Ziprasidone—Dyspnoea—Timolol—coronary artery disease	2.87e-05	0.000142	CcSEcCtD
Ziprasidone—Dizziness—Telmisartan—coronary artery disease	2.87e-05	0.000142	CcSEcCtD
Ziprasidone—Rash—Pravastatin—coronary artery disease	2.87e-05	0.000142	CcSEcCtD
Ziprasidone—Dermatitis—Pravastatin—coronary artery disease	2.87e-05	0.000141	CcSEcCtD
Ziprasidone—Decreased appetite—Ramipril—coronary artery disease	2.87e-05	0.000141	CcSEcCtD
Ziprasidone—Somnolence—Timolol—coronary artery disease	2.87e-05	0.000141	CcSEcCtD
Ziprasidone—Asthenia—Furosemide—coronary artery disease	2.86e-05	0.000141	CcSEcCtD
Ziprasidone—Headache—Pravastatin—coronary artery disease	2.85e-05	0.000141	CcSEcCtD
Ziprasidone—Anorexia—Lisinopril—coronary artery disease	2.85e-05	0.000141	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Ramipril—coronary artery disease	2.85e-05	0.00014	CcSEcCtD
Ziprasidone—Fatigue—Ramipril—coronary artery disease	2.84e-05	0.00014	CcSEcCtD
Ziprasidone—Dyspepsia—Timolol—coronary artery disease	2.84e-05	0.00014	CcSEcCtD
Ziprasidone—Hypersensitivity—Losartan—coronary artery disease	2.83e-05	0.00014	CcSEcCtD
Ziprasidone—Nausea—Valsartan—coronary artery disease	2.83e-05	0.000139	CcSEcCtD
Ziprasidone—Constipation—Ramipril—coronary artery disease	2.82e-05	0.000139	CcSEcCtD
Ziprasidone—Nausea—Olmesartan—coronary artery disease	2.81e-05	0.000139	CcSEcCtD
Ziprasidone—Vomiting—Trandolapril—coronary artery disease	2.81e-05	0.000139	CcSEcCtD
Ziprasidone—Diarrhoea—Perindopril—coronary artery disease	2.81e-05	0.000138	CcSEcCtD
Ziprasidone—Decreased appetite—Timolol—coronary artery disease	2.8e-05	0.000138	CcSEcCtD
Ziprasidone—Vomiting—Enalapril—coronary artery disease	2.8e-05	0.000138	CcSEcCtD
Ziprasidone—Hypotension—Lisinopril—coronary artery disease	2.8e-05	0.000138	CcSEcCtD
Ziprasidone—Dizziness—Captopril—coronary artery disease	2.79e-05	0.000138	CcSEcCtD
Ziprasidone—Rash—Trandolapril—coronary artery disease	2.79e-05	0.000137	CcSEcCtD
Ziprasidone—Dermatitis—Trandolapril—coronary artery disease	2.79e-05	0.000137	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Timolol—coronary artery disease	2.78e-05	0.000137	CcSEcCtD
Ziprasidone—Fatigue—Timolol—coronary artery disease	2.78e-05	0.000137	CcSEcCtD
Ziprasidone—Rash—Enalapril—coronary artery disease	2.78e-05	0.000137	CcSEcCtD
Ziprasidone—Dermatitis—Enalapril—coronary artery disease	2.77e-05	0.000137	CcSEcCtD
Ziprasidone—Headache—Trandolapril—coronary artery disease	2.77e-05	0.000137	CcSEcCtD
Ziprasidone—Vomiting—Telmisartan—coronary artery disease	2.76e-05	0.000136	CcSEcCtD
Ziprasidone—Asthenia—Losartan—coronary artery disease	2.76e-05	0.000136	CcSEcCtD
Ziprasidone—Headache—Enalapril—coronary artery disease	2.76e-05	0.000136	CcSEcCtD
Ziprasidone—Nausea—Niacin—coronary artery disease	2.75e-05	0.000135	CcSEcCtD
Ziprasidone—Rash—Telmisartan—coronary artery disease	2.74e-05	0.000135	CcSEcCtD
Ziprasidone—Dermatitis—Telmisartan—coronary artery disease	2.74e-05	0.000135	CcSEcCtD
Ziprasidone—Diarrhoea—Furosemide—coronary artery disease	2.73e-05	0.000135	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.73e-05	0.000134	CcSEcCtD
Ziprasidone—Headache—Telmisartan—coronary artery disease	2.72e-05	0.000134	CcSEcCtD
Ziprasidone—Feeling abnormal—Ramipril—coronary artery disease	2.72e-05	0.000134	CcSEcCtD
Ziprasidone—Dizziness—Perindopril—coronary artery disease	2.71e-05	0.000134	CcSEcCtD
Ziprasidone—Insomnia—Lisinopril—coronary artery disease	2.71e-05	0.000133	CcSEcCtD
Ziprasidone—Nausea—Pravastatin—coronary artery disease	2.7e-05	0.000133	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Ramipril—coronary artery disease	2.7e-05	0.000133	CcSEcCtD
Ziprasidone—Paraesthesia—Lisinopril—coronary artery disease	2.69e-05	0.000132	CcSEcCtD
Ziprasidone—Vomiting—Captopril—coronary artery disease	2.69e-05	0.000132	CcSEcCtD
Ziprasidone—Dyspnoea—Lisinopril—coronary artery disease	2.67e-05	0.000132	CcSEcCtD
Ziprasidone—Rash—Captopril—coronary artery disease	2.66e-05	0.000131	CcSEcCtD
Ziprasidone—Dermatitis—Captopril—coronary artery disease	2.66e-05	0.000131	CcSEcCtD
Ziprasidone—Somnolence—Lisinopril—coronary artery disease	2.66e-05	0.000131	CcSEcCtD
Ziprasidone—Feeling abnormal—Timolol—coronary artery disease	2.66e-05	0.000131	CcSEcCtD
Ziprasidone—Headache—Captopril—coronary artery disease	2.65e-05	0.00013	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Timolol—coronary artery disease	2.64e-05	0.00013	CcSEcCtD
Ziprasidone—Dizziness—Furosemide—coronary artery disease	2.64e-05	0.00013	CcSEcCtD
Ziprasidone—Dyspepsia—Lisinopril—coronary artery disease	2.63e-05	0.00013	CcSEcCtD
Ziprasidone—Diarrhoea—Losartan—coronary artery disease	2.63e-05	0.00013	CcSEcCtD
Ziprasidone—Nausea—Trandolapril—coronary artery disease	2.63e-05	0.00013	CcSEcCtD
Ziprasidone—Urticaria—Ramipril—coronary artery disease	2.62e-05	0.000129	CcSEcCtD
Ziprasidone—Nausea—Enalapril—coronary artery disease	2.62e-05	0.000129	CcSEcCtD
Ziprasidone—Vomiting—Perindopril—coronary artery disease	2.61e-05	0.000129	CcSEcCtD
Ziprasidone—Body temperature increased—Ramipril—coronary artery disease	2.61e-05	0.000129	CcSEcCtD
Ziprasidone—Abdominal pain—Ramipril—coronary artery disease	2.61e-05	0.000129	CcSEcCtD
Ziprasidone—Decreased appetite—Lisinopril—coronary artery disease	2.6e-05	0.000128	CcSEcCtD
Ziprasidone—Rash—Perindopril—coronary artery disease	2.59e-05	0.000128	CcSEcCtD
Ziprasidone—Dermatitis—Perindopril—coronary artery disease	2.58e-05	0.000127	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.58e-05	0.000127	CcSEcCtD
Ziprasidone—Nausea—Telmisartan—coronary artery disease	2.58e-05	0.000127	CcSEcCtD
Ziprasidone—Fatigue—Lisinopril—coronary artery disease	2.58e-05	0.000127	CcSEcCtD
Ziprasidone—Headache—Perindopril—coronary artery disease	2.57e-05	0.000127	CcSEcCtD
Ziprasidone—Urticaria—Timolol—coronary artery disease	2.56e-05	0.000126	CcSEcCtD
Ziprasidone—Constipation—Lisinopril—coronary artery disease	2.56e-05	0.000126	CcSEcCtD
Ziprasidone—Abdominal pain—Timolol—coronary artery disease	2.55e-05	0.000126	CcSEcCtD
Ziprasidone—Body temperature increased—Timolol—coronary artery disease	2.55e-05	0.000126	CcSEcCtD
Ziprasidone—Dizziness—Losartan—coronary artery disease	2.54e-05	0.000125	CcSEcCtD
Ziprasidone—Vomiting—Furosemide—coronary artery disease	2.53e-05	0.000125	CcSEcCtD
Ziprasidone—Rash—Furosemide—coronary artery disease	2.51e-05	0.000124	CcSEcCtD
Ziprasidone—Dermatitis—Furosemide—coronary artery disease	2.51e-05	0.000124	CcSEcCtD
Ziprasidone—Nausea—Captopril—coronary artery disease	2.51e-05	0.000124	CcSEcCtD
Ziprasidone—Headache—Furosemide—coronary artery disease	2.5e-05	0.000123	CcSEcCtD
Ziprasidone—Feeling abnormal—Lisinopril—coronary artery disease	2.47e-05	0.000122	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Lisinopril—coronary artery disease	2.45e-05	0.000121	CcSEcCtD
Ziprasidone—Vomiting—Losartan—coronary artery disease	2.45e-05	0.000121	CcSEcCtD
Ziprasidone—Nausea—Perindopril—coronary artery disease	2.44e-05	0.00012	CcSEcCtD
Ziprasidone—Hypersensitivity—Ramipril—coronary artery disease	2.43e-05	0.00012	CcSEcCtD
Ziprasidone—Rash—Losartan—coronary artery disease	2.43e-05	0.00012	CcSEcCtD
Ziprasidone—Dermatitis—Losartan—coronary artery disease	2.42e-05	0.000119	CcSEcCtD
Ziprasidone—Headache—Losartan—coronary artery disease	2.41e-05	0.000119	CcSEcCtD
Ziprasidone—Urticaria—Lisinopril—coronary artery disease	2.38e-05	0.000117	CcSEcCtD
Ziprasidone—Hypersensitivity—Timolol—coronary artery disease	2.38e-05	0.000117	CcSEcCtD
Ziprasidone—Nausea—Furosemide—coronary artery disease	2.37e-05	0.000117	CcSEcCtD
Ziprasidone—Asthenia—Ramipril—coronary artery disease	2.37e-05	0.000117	CcSEcCtD
Ziprasidone—Abdominal pain—Lisinopril—coronary artery disease	2.36e-05	0.000117	CcSEcCtD
Ziprasidone—Body temperature increased—Lisinopril—coronary artery disease	2.36e-05	0.000117	CcSEcCtD
Ziprasidone—Asthenia—Timolol—coronary artery disease	2.31e-05	0.000114	CcSEcCtD
Ziprasidone—Nausea—Losartan—coronary artery disease	2.28e-05	0.000113	CcSEcCtD
Ziprasidone—Diarrhoea—Ramipril—coronary artery disease	2.26e-05	0.000111	CcSEcCtD
Ziprasidone—Diarrhoea—Timolol—coronary artery disease	2.21e-05	0.000109	CcSEcCtD
Ziprasidone—Hypersensitivity—Lisinopril—coronary artery disease	2.2e-05	0.000109	CcSEcCtD
Ziprasidone—Dizziness—Ramipril—coronary artery disease	2.18e-05	0.000108	CcSEcCtD
Ziprasidone—Asthenia—Lisinopril—coronary artery disease	2.15e-05	0.000106	CcSEcCtD
Ziprasidone—Dizziness—Timolol—coronary artery disease	2.13e-05	0.000105	CcSEcCtD
Ziprasidone—Vomiting—Ramipril—coronary artery disease	2.1e-05	0.000103	CcSEcCtD
Ziprasidone—Rash—Ramipril—coronary artery disease	2.08e-05	0.000103	CcSEcCtD
Ziprasidone—Dermatitis—Ramipril—coronary artery disease	2.08e-05	0.000102	CcSEcCtD
Ziprasidone—Headache—Ramipril—coronary artery disease	2.07e-05	0.000102	CcSEcCtD
Ziprasidone—Vomiting—Timolol—coronary artery disease	2.05e-05	0.000101	CcSEcCtD
Ziprasidone—Diarrhoea—Lisinopril—coronary artery disease	2.05e-05	0.000101	CcSEcCtD
Ziprasidone—Rash—Timolol—coronary artery disease	2.03e-05	0.0001	CcSEcCtD
Ziprasidone—Dermatitis—Timolol—coronary artery disease	2.03e-05	0.0001	CcSEcCtD
Ziprasidone—Headache—Timolol—coronary artery disease	2.02e-05	9.96e-05	CcSEcCtD
Ziprasidone—Dizziness—Lisinopril—coronary artery disease	1.98e-05	9.75e-05	CcSEcCtD
Ziprasidone—Nausea—Ramipril—coronary artery disease	1.96e-05	9.66e-05	CcSEcCtD
Ziprasidone—Nausea—Timolol—coronary artery disease	1.92e-05	9.44e-05	CcSEcCtD
Ziprasidone—Vomiting—Lisinopril—coronary artery disease	1.9e-05	9.38e-05	CcSEcCtD
Ziprasidone—Rash—Lisinopril—coronary artery disease	1.89e-05	9.3e-05	CcSEcCtD
Ziprasidone—Dermatitis—Lisinopril—coronary artery disease	1.88e-05	9.29e-05	CcSEcCtD
Ziprasidone—Headache—Lisinopril—coronary artery disease	1.87e-05	9.24e-05	CcSEcCtD
Ziprasidone—Nausea—Lisinopril—coronary artery disease	1.78e-05	8.76e-05	CcSEcCtD
Ziprasidone—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	8.53e-07	6.23e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—APOE—coronary artery disease	8.52e-07	6.23e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	8.5e-07	6.22e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	8.5e-07	6.22e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	8.5e-07	6.21e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ABCA1—coronary artery disease	8.47e-07	6.19e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	8.42e-07	6.16e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—APOA1—coronary artery disease	8.42e-07	6.16e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	8.42e-07	6.15e-06	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TGFB1—coronary artery disease	8.41e-07	6.15e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—GPX1—coronary artery disease	8.4e-07	6.14e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	8.4e-07	6.14e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	8.39e-07	6.14e-06	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—AKT1—coronary artery disease	8.38e-07	6.13e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	8.37e-07	6.12e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MMP9—coronary artery disease	8.36e-07	6.11e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	8.33e-07	6.09e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MMP9—coronary artery disease	8.32e-07	6.08e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	8.3e-07	6.07e-06	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—MAPK1—coronary artery disease	8.24e-07	6.03e-06	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PTGS2—coronary artery disease	8.21e-07	6e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GOT1—coronary artery disease	8.2e-07	5.99e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GGT1—coronary artery disease	8.2e-07	5.99e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	8.2e-07	5.99e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	8.19e-07	5.99e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CD36—coronary artery disease	8.18e-07	5.98e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CXCL8—coronary artery disease	8.11e-07	5.93e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	8.11e-07	5.93e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	8.09e-07	5.91e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PPP2CA—coronary artery disease	8.08e-07	5.9e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	8.06e-07	5.9e-06	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TGFB1—coronary artery disease	8.01e-07	5.86e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	7.98e-07	5.84e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CXCL8—coronary artery disease	7.97e-07	5.82e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	7.96e-07	5.82e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	7.96e-07	5.82e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	7.94e-07	5.81e-06	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—PIK3CA—coronary artery disease	7.92e-07	5.79e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	7.92e-07	5.79e-06	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—PIK3CA—coronary artery disease	7.91e-07	5.78e-06	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TGFB1—coronary artery disease	7.9e-07	5.78e-06	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—PIK3CA—coronary artery disease	7.86e-07	5.75e-06	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—MAPK1—coronary artery disease	7.86e-07	5.74e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	7.84e-07	5.73e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	7.84e-07	5.73e-06	CbGpPWpGaD
Ziprasidone—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	7.84e-07	5.73e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	7.82e-07	5.71e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	7.8e-07	5.7e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	7.77e-07	5.68e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CASP3—coronary artery disease	7.77e-07	5.68e-06	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—MAPK1—coronary artery disease	7.75e-07	5.67e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—MTHFR—coronary artery disease	7.75e-07	5.67e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	7.72e-07	5.64e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—IL6—coronary artery disease	7.71e-07	5.64e-06	CbGpPWpGaD
Ziprasidone—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	7.71e-07	5.64e-06	CbGpPWpGaD
Ziprasidone—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	7.7e-07	5.63e-06	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—PIK3CA—coronary artery disease	7.7e-07	5.63e-06	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	7.67e-07	5.61e-06	CbGpPWpGaD
Ziprasidone—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	7.65e-07	5.59e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CASP3—coronary artery disease	7.64e-07	5.59e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CASP3—coronary artery disease	7.62e-07	5.57e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CASP3—coronary artery disease	7.6e-07	5.56e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—IL6—coronary artery disease	7.59e-07	5.55e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CASP3—coronary artery disease	7.58e-07	5.54e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—IL6—coronary artery disease	7.57e-07	5.54e-06	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—PIK3CA—coronary artery disease	7.57e-07	5.54e-06	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	7.57e-07	5.54e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CCND1—coronary artery disease	7.56e-07	5.53e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	7.55e-07	5.52e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—IL6—coronary artery disease	7.55e-07	5.52e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—IL6—coronary artery disease	7.53e-07	5.5e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	7.51e-07	5.49e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CASP3—coronary artery disease	7.5e-07	5.48e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	7.48e-07	5.47e-06	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—PIK3CA—coronary artery disease	7.47e-07	5.46e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	7.47e-07	5.46e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—IL6—coronary artery disease	7.45e-07	5.45e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CCND1—coronary artery disease	7.44e-07	5.44e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	7.43e-07	5.43e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CCND1—coronary artery disease	7.42e-07	5.43e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PPARG—coronary artery disease	7.42e-07	5.42e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CCND1—coronary artery disease	7.4e-07	5.41e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CCND1—coronary artery disease	7.37e-07	5.39e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GSTP1—coronary artery disease	7.36e-07	5.38e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—AGT—coronary artery disease	7.36e-07	5.38e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MMP9—coronary artery disease	7.34e-07	5.37e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—POMC—coronary artery disease	7.32e-07	5.35e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CCND1—coronary artery disease	7.3e-07	5.34e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	7.3e-07	5.33e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	7.28e-07	5.32e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—HMOX1—coronary artery disease	7.26e-07	5.31e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	7.26e-07	5.31e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	7.26e-07	5.31e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MMP9—coronary artery disease	7.22e-07	5.28e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—APOE—coronary artery disease	7.22e-07	5.27e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MMP9—coronary artery disease	7.21e-07	5.27e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MMP9—coronary artery disease	7.18e-07	5.25e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CAT—coronary artery disease	7.17e-07	5.24e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MMP9—coronary artery disease	7.16e-07	5.23e-06	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—PIK3CA—coronary artery disease	7.15e-07	5.23e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	7.15e-07	5.23e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	7.14e-07	5.22e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—APOA1—coronary artery disease	7.13e-07	5.21e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—AKT1—coronary artery disease	7.12e-07	5.2e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MMP9—coronary artery disease	7.09e-07	5.18e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	7.07e-07	5.17e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	7.02e-07	5.13e-06	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—IL6—coronary artery disease	7.01e-07	5.13e-06	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—IL6—coronary artery disease	7e-07	5.12e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	7e-07	5.12e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	7e-07	5.12e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—AKT1—coronary artery disease	6.99e-07	5.11e-06	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—PIK3CA—coronary artery disease	6.99e-07	5.11e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	6.97e-07	5.09e-06	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—IL6—coronary artery disease	6.96e-07	5.09e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—APOB—coronary artery disease	6.96e-07	5.09e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	6.95e-07	5.08e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	6.94e-07	5.08e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	6.91e-07	5.05e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	6.89e-07	5.04e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	6.88e-07	5.03e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	6.86e-07	5.01e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	6.85e-07	5.01e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	6.83e-07	4.99e-06	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—PIK3CA—coronary artery disease	6.82e-07	4.98e-06	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—IL6—coronary artery disease	6.81e-07	4.98e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—PIK3CA—coronary artery disease	6.78e-07	4.96e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GSTM1—coronary artery disease	6.77e-07	4.95e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	6.77e-07	4.95e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	6.76e-07	4.94e-06	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—PIK3CA—coronary artery disease	6.73e-07	4.92e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	6.72e-07	4.91e-06	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—IL6—coronary artery disease	6.71e-07	4.9e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—ALB—coronary artery disease	6.67e-07	4.88e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	6.67e-07	4.87e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—LPL—coronary artery disease	6.64e-07	4.86e-06	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—IL6—coronary artery disease	6.61e-07	4.84e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—VEGFA—coronary artery disease	6.59e-07	4.82e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	6.57e-07	4.8e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	6.56e-07	4.8e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	6.54e-07	4.78e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	6.48e-07	4.74e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GPX1—coronary artery disease	6.48e-07	4.74e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—VEGFA—coronary artery disease	6.47e-07	4.73e-06	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—AKT1—coronary artery disease	6.47e-07	4.73e-06	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—AKT1—coronary artery disease	6.46e-07	4.72e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	6.45e-07	4.71e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	6.43e-07	4.7e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	6.43e-07	4.7e-06	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—AKT1—coronary artery disease	6.42e-07	4.69e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—NOS3—coronary artery disease	6.38e-07	4.66e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	6.37e-07	4.66e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	6.37e-07	4.65e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	6.35e-07	4.64e-06	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IL6—coronary artery disease	6.33e-07	4.63e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CD36—coronary artery disease	6.31e-07	4.61e-06	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—AKT1—coronary artery disease	6.29e-07	4.6e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PPARG—coronary artery disease	6.28e-07	4.59e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PPP2CA—coronary artery disease	6.23e-07	4.56e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—POMC—coronary artery disease	6.2e-07	4.53e-06	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—AKT1—coronary artery disease	6.19e-07	4.52e-06	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—AKT1—coronary artery disease	6.1e-07	4.46e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	6.07e-07	4.44e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TGFB1—coronary artery disease	6.05e-07	4.42e-06	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL6—coronary artery disease	6.04e-07	4.41e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—PIK3CA—coronary artery disease	6e-07	4.39e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—MTHFR—coronary artery disease	5.98e-07	4.37e-06	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL6—coronary artery disease	5.96e-07	4.35e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	5.95e-07	4.35e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TGFB1—coronary artery disease	5.94e-07	4.34e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MAPK1—coronary artery disease	5.93e-07	4.34e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	5.92e-07	4.33e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	5.9e-07	4.31e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	5.9e-07	4.31e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	5.86e-07	4.29e-06	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—AKT1—coronary artery disease	5.84e-07	4.27e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	5.84e-07	4.27e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	5.84e-07	4.27e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PTGS2—coronary artery disease	5.84e-07	4.27e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	5.83e-07	4.26e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	5.83e-07	4.26e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MAPK1—coronary artery disease	5.82e-07	4.26e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	5.8e-07	4.24e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	5.79e-07	4.23e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	5.73e-07	4.19e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	5.71e-07	4.18e-06	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—AKT1—coronary artery disease	5.71e-07	4.17e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—AGT—coronary artery disease	5.68e-07	4.15e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	5.67e-07	4.15e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—ALB—coronary artery disease	5.65e-07	4.13e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	5.58e-07	4.08e-06	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—AKT1—coronary artery disease	5.57e-07	4.07e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—APOE—coronary artery disease	5.57e-07	4.07e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—AKT1—coronary artery disease	5.54e-07	4.05e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—PIK3CA—coronary artery disease	5.51e-07	4.03e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—APOA1—coronary artery disease	5.5e-07	4.02e-06	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—AKT1—coronary artery disease	5.49e-07	4.02e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	5.41e-07	3.96e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—NOS3—coronary artery disease	5.41e-07	3.95e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL6—coronary artery disease	5.38e-07	3.93e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	5.31e-07	3.88e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL6—coronary artery disease	5.19e-07	3.79e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL6—coronary artery disease	5.16e-07	3.78e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	5.15e-07	3.76e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	5.06e-07	3.7e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	5.05e-07	3.69e-06	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PIK3CA—coronary artery disease	5.05e-07	3.69e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	5.04e-07	3.68e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL6—coronary artery disease	5.02e-07	3.67e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	5.02e-07	3.67e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	4.97e-07	3.64e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	4.96e-07	3.63e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	4.96e-07	3.63e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PTGS2—coronary artery disease	4.94e-07	3.61e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL6—coronary artery disease	4.94e-07	3.61e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—AKT1—coronary artery disease	4.91e-07	3.59e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PPARG—coronary artery disease	4.85e-07	3.55e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—AKT1—coronary artery disease	4.79e-07	3.5e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—POMC—coronary artery disease	4.78e-07	3.5e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—AKT1—coronary artery disease	4.76e-07	3.48e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	4.63e-07	3.39e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	4.61e-07	3.37e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	4.56e-07	3.33e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL6—coronary artery disease	4.56e-07	3.33e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—AKT1—coronary artery disease	4.5e-07	3.29e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL6—coronary artery disease	4.48e-07	3.28e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL6—coronary artery disease	4.47e-07	3.27e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL6—coronary artery disease	4.46e-07	3.26e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL6—coronary artery disease	4.45e-07	3.25e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL6—coronary artery disease	4.4e-07	3.22e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL6—coronary artery disease	4.39e-07	3.21e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ALB—coronary artery disease	4.36e-07	3.19e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—AKT1—coronary artery disease	4.2e-07	3.07e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—NOS3—coronary artery disease	4.17e-07	3.05e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—AKT1—coronary artery disease	4.14e-07	3.02e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—AKT1—coronary artery disease	4.13e-07	3.02e-06	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—AKT1—coronary artery disease	4.12e-07	3.02e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—AKT1—coronary artery disease	4.11e-07	3.01e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—AKT1—coronary artery disease	4.1e-07	3e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL6—coronary artery disease	4.08e-07	2.98e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—AKT1—coronary artery disease	4.06e-07	2.97e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	4.05e-07	2.96e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PTGS2—coronary artery disease	3.82e-07	2.79e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	3.76e-07	2.75e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PIK3CA—coronary artery disease	3.59e-07	2.62e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PIK3CA—coronary artery disease	3.04e-07	2.22e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—AKT1—coronary artery disease	2.93e-07	2.14e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—AKT1—coronary artery disease	2.48e-07	1.82e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.35e-07	1.72e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—AKT1—coronary artery disease	1.92e-07	1.4e-06	CbGpPWpGaD
